Chennai-based Orchid Pharma Limited has submitted its Confirmation Certificate under Regulation 74(5) of SEBI’s Depositories and Participants Regulations, 2018 to the stock exchanges for the quarter ended March 31, 2026. 

The filing, dated April 9, 2026, confirms that all securities received for dematerialisation during the quarter were duly processed and the relevant certificates were updated within the prescribed timelines. 

The certificate was issued by the company’s Registrar and Share Transfer Agent, Abhipra Capital Limited, underscoring Orchid Pharma’s continued adherence to shareholder service and listing compliance requirements.